In the ever-evolving landscape of oncology, targeted therapies have revolutionized cancer treatment. Bosutinib, a vital medication for chronic myeloid leukemia (CML) and other cancers, stands as a testament to this progress. The synthesis of such complex molecules relies heavily on the availability and quality of their constituent intermediates. Among these, 4-Chloro-7-(3-chloropropoxy)-6-methoxyquinoline-3-carbonitrile, identified by CAS number 214470-68-5, plays a pivotal role.

This advanced pharmaceutical intermediate is not merely a chemical compound; it is a critical building block that enables the efficient and often environmentally conscious production of Bosutinib. Its specific molecular structure is precisely engineered to facilitate downstream reactions, ultimately leading to the formation of the active pharmaceutical ingredient. For R&D scientists and procurement managers in the pharmaceutical industry, understanding the properties and sourcing options for CAS 214470-68-5 is essential. We, as a specialized supplier, ensure that this intermediate is manufactured to meet exacting standards, guaranteeing its suitability for pharmaceutical applications.

The journey from basic chemical precursors to a life-saving drug is complex, and intermediates like 4-Chloro-7-(3-chloropropoxy)-6-methoxyquinoline-3-carbonitrile are indispensable links in this chain. When you are looking to purchase this intermediate, you are essentially investing in the quality and reliability of your final product. Our objective is to simplify this process by offering a readily available, high-purity product from a trusted manufacturer. We provide clear specifications, including appearance (white powder) and purity (≥98.0%), allowing our clients to make informed decisions about their supply chain.

The market demand for innovative cancer treatments continues to grow, directly influencing the demand for essential intermediates like CAS 214470-68-5. As a leading supplier, we are dedicated to meeting this demand with consistent quality and responsive service. We invite industry professionals to inquire about the price of this critical intermediate and explore how our reliable supply can support their oncology drug development pipelines. Partnering with us means securing a critical component for advancing cancer therapies.